Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease.

Coogan PF, Rosenberg L, Louik C, Zauber AG, Stolley PD, Strom BL, Shapiro S.

Cancer Causes Control. 2000 Mar;11(3):249-55.

PMID:
10782659
2.

Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.

Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL.

Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):955-60.

3.

Statin use and risk of colorectal cancer.

Coogan PF, Smith J, Rosenberg L.

J Natl Cancer Inst. 2007 Jan 3;99(1):32-40.

4.

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.

Peleg II, Maibach HT, Brown SH, Wilcox CM.

Arch Intern Med. 1994 Feb 28;154(4):394-9.

PMID:
8117171
5.

Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.

Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF.

Gastroenterology. 2007 Aug;133(2):393-402. Epub 2007 May 21.

PMID:
17681160
6.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

7.

Nonsteroidal antiinflammatory drugs and colorectal cancer.

Muscat JE, Stellman SD, Wynder EL.

Cancer. 1994 Oct 1;74(7):1847-54.

8.

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

García-Rodríguez LA, Huerta-Alvarez C.

Epidemiology. 2001 Jan;12(1):88-93.

PMID:
11138826
9.

PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.

Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):616-9. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3020.

10.

No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.

Siemes C, Eijgelsheim M, Dieleman JP, van Schaik RH, Uitterlinden AG, van Duijn CM, Hofman A, Coebergh JW, Stricker BH, Visser LE.

Neth J Med. 2009 Apr;67(4):134-41.

11.

The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer.

Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S.

Prev Med. 1999 Aug;29(2):72-6.

PMID:
10446030
12.

Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?

Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, Wargovich M, Coker A, Hebert JR.

Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):631-7.

13.

Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study.

Smalley W, Ray WA, Daugherty J, Griffin MR.

Arch Intern Med. 1999 Jan 25;159(2):161-6.

PMID:
9927099
14.

Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?

Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J.

Pharmacogenet Genomics. 2007 Aug;17(8):639-45.

PMID:
17622940
15.

Family history and risk of colorectal cancer in the multiethnic population of Hawaii.

Le Marchand L, Zhao LP, Quiaoit F, Wilkens LR, Kolonel LN.

Am J Epidemiol. 1996 Dec 15;144(12):1122-8.

16.

Interactions of familial and hormonal risk factors for large bowel cancer in women.

Newcomb PA, Taylor JO, Trentham-Dietz A.

Int J Epidemiol. 1999 Aug;28(4):603-8.

17.

Risk of colorectal cancer in relatives: a case control study.

Safaee A, Moghimi-Dehkordi B, Pourhoseingholi MA, Vahedi M, Maserat E, Ghiasi S, Fatemi SR, Zali MR.

Indian J Cancer. 2010 Jan-Mar;47(1):27-30. doi: 10.4103/0019-509X.58855.

18.

Risk factors of colorectal cancer in inflammatory bowel disease.

Bansal P, Sonnenberg A.

Am J Gastroenterol. 1996 Jan;91(1):44-8.

PMID:
8561142
19.

Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.

Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, Neuhausen S.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):538-45.

20.

Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.

Chia VM, Newcomb PA, Bigler J, Morimoto LM, Thibodeau SN, Potter JD.

Cancer Res. 2006 Jul 1;66(13):6877-83.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk